PROFESSIONAL EDITION

The largest community of pharma leaders

Admin

3307 articles

U.S. FDA Expands Approval of Pfizer’s LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung Cancer

NEW YORK--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE: PFE) supplemental New Drug Application (sNDA) for LORBRENA® (lorlatinib), expanding the...

Oregon Bioscience Association Appoints 2021 Leadership

PORTLAND, Ore.--(BUSINESS WIRE)--Dan Snyder, MBA, local medical diagnostics corporate executive, will lead 2021 Oregon Bioscience Association (Oregon Bio)’s board of directors. With Snyder, Executive Committee...

Glaukos Appoints Denice Torres and Dr. Leana Wen to its Board of Directors

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal...

Shorla Pharma Announces U.S. Industry Veteran Nicholas Holsman as Chief Commercial Officer

CLONMEL, Ireland--(BUSINESS WIRE)--Shorla Pharma Limited (‘Shorla’), a specialty pharmaceutical company, announces the appointment of Chief Commercial Officer Nicholas Holsman, a highly experienced U.S. industry...

Iktos Announces Collaboration With Pfizer in AI for Drug Design

PARIS--(BUSINESS WIRE)--Iktos announced today the application of Iktos Artificial Intelligence technology for de novo design to selected Pfizer small-molecule discovery programs. Over the last few...

BiomX Announces Dosing of First Subject in Phase 2 Study of BX001 for Acne-Prone Skin

NESS ZIONA, Israel--(BUSINESS WIRE)--BiomX Inc. (NYSE American: PHGE), a clinical-stage company developing both natural and engineered phage therapies that target specific pathogenic bacteria, today...